Menta Capital’s CONMED CNMD Stock Holding History

Menta Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,650	Closed	-$279K	–	865
2016 Q1	$279K	Buy	+6,650	New	+$261K	0.04%	719

Other funds holding CNMD

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Menta Capital's CNMD Position: Q2 2016 in Review

Menta Capital sold out of CONMED (CNMD) in Q2 2016, closing a stake of 6,650 shares — an estimated $279K sold.

Menta Capital first reported a position in CNMD in Q1 2016 and held it in 1 quarter. The position peaked at $279K in Q1 2016. 154 funds tracked by Wall St. Rank hold CNMD as of Q2 2016.

Menta Capital reported no remaining CONMED position as of Q2 2016 after selling out during the quarter.
Menta Capital sold 6,650 CONMED shares in Q2 2016, an estimated $279K.
Menta Capital first reported a position in CONMED in Q1 2016 and held it in 1 quarter.
Menta Capital's CONMED position peaked at $279K in Q1 2016.
154 funds tracked by Wall St. Rank held CONMED as of Q2 2016.

Based on Menta Capital's 13F filing for Q2 2016, filed 12 Aug 2016.